Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies

British Journal of Radiology

Volumn 80, Issue 949, 2007, Pages 3-11

  Fukuchi, K ^a,c   Ohta, H ^b   Matsumura, K ^b   Ishida, Y ^c  

^a SHIZUOKA GENERAL HOSPITAL   (Japan)

^b Higashitemma Clinic   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM NITRATE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DRUG ACCUMULATION; DRUG UPTAKE; ELECTROCARDIOGRAPHY; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE; HEART TUMOR; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PULMONARY HYPERTENSION; REVIEW; SARCOIDOSIS; TREATMENT INDICATION; HEART DISEASE; INCIDENTAL FINDING; METHODOLOGY; NEOPLASM; SCINTISCANNING;

FASTING; FLUORODEOXYGLUCOSE F18; HEART DISEASES; HUMANS; INCIDENTAL FINDINGS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 33947532256     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/92105597     Document Type: Review

References (31)

1. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77.
2. Yamanouchi M, Yoshida K, Niwayama H, Nakagawa K, Aioi S, Shikama N, et al. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males. Jpn Circ J 1996;60:319-27.
3. Bacharach SL, Bax JJ, Case J, Delbeke D, Kurdziel KA, Martin WH, et al. PET myocardial glucose metabolism and perfusion imaging: Part I-Guidelines for data acquisition and patient preparation. J Nucl Cardiol 2003;10:543-56.
4. de Groot M, Meeuwis AP, Kok PJ, Corstens FH, Oyen WJ. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 2005;32:98-101.
5. Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990;31:1749-56.
6. Von Schulthess GK. Normal PET and PET/CT body scans: imaging pitfalls and artifacts. In: Von Schulthess GK, editor. Clinical molecular anatomical imaging. Philadelphia, PA: Lippincott Williams & Wilkins, 2003:251-3.
7. Page DL. Lipomatous hypertrophy of the cardiac interatrial septum: its development and probable clinical significance. Hum Pathol 1970;1:151-63.
8. Fan CM, Fischman AJ, Kwek BH, Abbara S, Aquino SL. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. AJR Am J Roentgenol 2005;184:339-42.
9. 18F fluorodeoxyglucose positron emission tomography/CT. Chest 2005;128:3888-93.
10. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32:217-38.
11. Schwaiger M, Schelbert HR, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985;6:336-47.
12. Lopaschuk GD, Stanley WC. Glucose metabolism in the ischemic heart. Circulation 1997;95:313-5.
13. Fujii H, Ide M, Yasuda S, Takahashi W, Shohtsu A, Kubo A. Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET. Ann Nucl Med 1999;13:55-9.
14. Boyden PA, Hoffman BF. The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs. Circ Res 1981;49:1319-31.
15. Cabrera JA, Sanchez-Quintana D, Ho SY, Medina A, Wanguemert F, Gross E, et al. Angiographic anatomy of the inferior right atrial isthmus in patients with and without history of common atrial flutter. Circulation 1999;99:3017-23.
16. Zanco P, Desideri A, Mobilia G, Cargnel S, Milan E, Celegon L, et al. Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses. J Nucl Med 2000;41:973-7.
17. Ivens E. Hypertrophic cardiomyopathy. Heart Lung Circ 2004;13:S48-55.
18. Ishida Y, Nagata S, Uehara T, Yasumura Y, Fukuchi K, Miyatake K. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography. J Cardiol 2001;37:121-8.
19. 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy. Ann Nucl Med 2000;14:33-8.
20. Kluge R, Barthel H, Pankau H, Seese A, Schauer J, Wirtz H, et al. Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med 2005;46:25-31.
21. Foroulis CN, Kotoulas CS, Kakouros S, Evangelatos G, Chassapis C, Konstantinou M, et al. Study on the late effect of pneumonectomy on right heart pressures using Doppler echocardiography. Eur J Cardiothorac Surg 2004;26:508-14.
22. James DG. Descriptive definition and historic aspects of sarcoidosis. Clin Chest Med 1997;18:663-79.
23. 18F-FDG PET. J Nucl Med 2003; 44:1030-6.
24. Tadamura E, Yamamuro M, Kubo S, Kanao S, Saga T, Harada M, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 2005;185: 110-5.
25. 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26: 1538-43.
26. Agostini D, Babatasi G, Galateau F, Grollier G, Potier JC, Bouvard G. Detection of cardiac myxoma by F-18 FDG PET. Clin Nucl Med 1999;24:159-60.
27. Gibbs P, Cebon JS, Calafiore P, Robinson WA. Cardiac metastases from malignant melanoma. Cancer 1999;85: 78-84.
28. Shimotsu Y, Ishida Y, Fukuchi K, Hayashida K, Toba M, Hamada S, et al. Fluorine-18-fluorodeoxyglucose PET identification of cardiac metastasis arising from uterine cervical carcinoma. J Nucl Med 1998;39:2084-7.
29. Romer W, Garbrecht M, Fuchs C, Schwaiger M. Images in cardiovascular medicine. Metabolic imaging identifies non-Hodgkin's lymphoma infiltrating heart. Circulation 1998;97:2577-8.
30. Plutchok JJ, Boxt LM, Weinberger J, Fawwaz R, Sherman WH, Van Heertum RL. Differentiation of cardiac tumor from thrombus by combined MRI and F-18 EDG PET imaging. Clin Nucl Med 1998;23:324-5.
31. Iwahashi N, Nakatani S, Kakuchi H, Yamagishi M, Fukuchi K, Ishida Y, et al. Cardiac tumor as an initial manifestation of acquired immunodeficiency syndrome. Circ J 2005;69: 243-5.